InClin Announces Quasar Publication Featuring First Virtual Inspection Conducted by the European Medicines Agency (EMA)

SAN MATEO, Calif.--(BUSINESS WIRE)--InClin, Inc., a full-service Contract Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney, Australia, today announced the publication of a manuscript entitled: “The New Norm: A Global Virtual GCP Preapproval EMA Inspection" in Issue #154 January 2021 edition of Quasar, the Research Quality Association’s (RQA) quarterly journal. The article describes how the European Medicines Agency (EMA) and sponsor collaborated to successfully

Click to view original post